Accueil
Mots-clés
Ajouter le résultat dans votre panier Faire une suggestion Affiner la rechercheRapport
FRANÇAIS : Ce rapport de l'OEDT offre un tour d'horizon du phénomène de la toxicomanie en Europe : il fournit des renseignements sur les différents types de consommation, des données comparatives d'ordre épidémiologique ou encore des chiffres [...]Rapport
FRANÇAIS : Le quatrième rapport annuel de l'EMCDDA présente les données et statistiques comparées les plus récentes concernant les drogues et toxicomanies dans les Etats membres de l'Union Européenne. Après une présentation des traitements, de[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug[...]Rapport
This publication presents the data and findings of the risk assessment on N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide (4F-iBF), carried out by the extended Scientific Committee of the EMCDDA on 7-8 November 2017. I[...]Rapport
This report presents the data and findings of the risk assessment on the new psychoactive substance, 5-(2-aminopropyl)indole, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant [...]Rapport
This publication presents the data and findings of the risk assessment on methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 N[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7-8 No[...]Texte legislatif
EXTRAIT Article 1. - Participation. La République de Croatie participe pleinement aux activités de l'Observatoire, selon les modalités énoncées dans le présent accord. Article 2. - Réseau européen d'information sur les drogues et les toxicoman[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1 phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 22 February 2017. On the basis of th[...]Texte legislatif
EXTRAIT CONSIDÉRANT que les dangers particuliers inhérents à l'évolution des drogues de synthèse exigent une action rapide de la part des États membres ; [...] Article 1er. - Objectifs La présente action commune vise à créer un système d'éc[...]Rapport
This publication presents the data and findings of the risk assessment on N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA), carried out by the extended Scientific Committee of the EMCDDA on 7[...]Article : Périodique
P. GRIFFITHS ; J. MOUNTENEY ; D. LOPEZ ; F. ZOBEL ; W. GÖTZ |The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the designated hub for drug-related information in the European Union. The organization's role is to provide the European Union (EU) and its Member States with a factual ove[...]Chapitre
The alternatives to prison that may be offered to drug-using offenders cover a range of sanctions that may delay, avoid, replace or complement prison sentences for those drug users who have committed an offence normally sanctioned with imprisonm[...]Rapport
Based on the options provided by the international drug control legal framework, this paper considers the rehabilitative measures of treating, educating or reintegrating drug users as alternatives or additions to conviction or punishment that ar[...]
